Waters Corporation (NYSE:WAT) stock is trading lower on Monday after the company released fourth-quarter 2025 financial results and issued fiscal 2026 guidance.Fourth Quarter Earnings SnapshotThe company reported quarterly sales of $932.36 million, an increase of 7% as reported and 6% in constant currency, beating the consensus of $928.09 million.Sales into the academic and government market decreased 2% as reported and 3% in constant currency.The analytical instruments provider reported adjusted earnings o ...

Waters (NYSE:WAT) Q4 2025 Earnings call February 09, 2026 08:30 AM ET Company ParticipantsAmol Chaubal - SVP and CFOCaspar Tudor - Head of Investor RelationsUdit Batra - President and CEOConference Call ParticipantsCatherine Schulte - Senior Research Analyst and Director, Life Sciences and DiagnosticsDoug Schenkel - Managing Director, Senior Research Analyst and Head of Life Science Tools and DiagnosticsJack Meehan - Equity Research Analyst, Life Science Tools and DiagnosticsTycho Peterson - Managing Direct ...

Company Overview - Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving various sectors including life sciences, materials, food, and environmental sciences for over 65 years [2] - The company ensures the efficacy of medicines, safety of food, purity of water, and quality and sustainability of everyday products [2] - Waters Corporation operates in over 100 countries with a workforce of more than 7,600 employees who collaborate with customers in laboratories, manufacturing sites, and hospitals [2] Financial Results Announcement - Waters Corporation will hold its Q4 2025 financial results conference call on February 12, 2026, at 8:00 a.m. Eastern Time [1] - A live webcast of the presentation will be available on the Waters Investor Relations website, with a replay accessible until at least March 12, 2026 [1]

Group 1 - Waters Corporation will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12th, 2026, at 2:15 PM Pacific Time [1] - A live webcast of the presentation will be available on the Waters Investor Relations website, with a replay accessible for 90 days [1] Group 2 - Waters Corporation is a global leader in analytical instruments, separations technologies, and software, serving various sectors for over 65 years [2] - The company focuses on ensuring the efficacy of medicines, safety of food, purity of water, and quality of everyday products [2] - Waters Corporation operates in over 100 countries with a workforce of more than 7,600 employees [2]

Core Viewpoint - Morgan Stanley initiated coverage of Agilent Technologies with an Overweight rating and a $180 price target, highlighting the company's strategic initiatives and "Ignite" transformation program aimed at accelerating growth in key analytical and diagnostics markets [1] Group 1: Strategic Initiatives - Agilent's platform technologies, workflow automation, and services are increasingly aligned with customer needs in analytical labs, especially as tighter budgets and labor shortages drive demand for efficiency solutions [2] - The company's leadership in gas chromatography and spectroscopy, along with expanding opportunities in battery materials, semiconductors, and PFAS regulatory compliance, is expected to support long-term growth [2] Group 2: Revenue Generation - Agilent's CrossLab Group, which generated approximately 42% of FY24 revenue, is considered an underappreciated asset that enhances customer retention and recurring revenue [3] - The increased focus on biopharma and diagnostics, including the acquisition of BIOVECTRA and the expansion of the Dako Omnis pathology platform, presents additional growth opportunities as the sector continues to recover [3]

Core Insights - Waters Corporation is a leading analytical instruments and software company with a market cap of $22.4 billion, specializing in high-performance liquid chromatography, mass spectrometry, and laboratory informatics [1] Performance Overview - Over the past year, Waters shares have increased by 5.8%, underperforming the S&P 500 Index, which has risen by nearly 10.5% [2] - Year-to-date in 2025, WAT stock is up 2.1%, while the S&P 500 has seen an 11.2% rise [2] Sector Comparison - Waters has also underperformed compared to the Health Care Select Sector SPDR Fund, which gained 6% over the past year and 10.1% year-to-date [3] Recent Financial Performance - On November 4, Waters reported stronger-than-expected third-quarter results, with revenue of $800 million, an 8% year-over-year increase, driven by demand in pharmaceuticals and growth in recurring revenue streams [4] - Adjusted EPS surged to $3.40, reflecting a 16% increase from the previous year, aided by improved margins and accelerated instrument replacement cycles [4] Growth Drivers - Strength in LC-MS systems, double-digit growth in chemistry, and an 11% boost in pharmaceutical end-markets contributed to the company's momentum [5] - Waters raised its full-year sales and earnings guidance, indicating confidence in demand outlook [5] - Analysts expect WAT's EPS to grow by 10.5% to $13.10 on a diluted basis for the current fiscal year ending in December [5] Analyst Sentiment - Among 15 analysts covering WAT stock, the consensus rating is a "Moderate Buy," consisting of five "Strong Buy" ratings and ten "Holds" [6] - Rothschild & Co initiated coverage on Waters with a "Buy" rating and set a price target of $390, drawing renewed attention to the stock [7]

钴是一种战略性稀有金属，广泛用于锂电池正极材料、高温合金及硬质工具。钴矿主要与基性—超 基性岩或沉积型层控矿床相关，常与铜、镍等元素共生，矿物嵌布复杂，品位普遍偏低。 VantaMax&VantaCore可对样品进行直接检测，无需对样品进行特殊处理，可在20秒内得到样品元 素成分的定性及定量信息，测钴检出限低至2ppm。现场实验室一般要花费几个小时甚至几天才能得出 分析结果，而使用Vanta分析仪，用户短时间内即能获得具有实验室分析水平的精准结果。 Evident为地球科学行业提供种类齐全的产品和解决方案，帮助用户确定地质样品的特性，从而为 用户提供一套完整的性价比高的样品定性解决方案。（刘亚丽） 钴矿开采面临矿体形态多变、有害元素（如砷）伴生及微细粒钴难分离等挑战。传统选矿工艺难以 高效富集，且化学分析易受铁、锰等元素干扰，需高精度现场检测指导分选。 在 我 国 青 海 某 大 型 铜 钴 矿 勘 查 中 ， 技 术 人 员 使 用 Evident 手 持 式 X 射 线 荧 光 分 析 仪 （VantaMax&VantaCore）对岩心样品进行快速检测。样品破碎至1毫米后，仪器20秒内完成钴、铜、镍 等元 ...

Core Insights - Waters Corporation will have its President and CEO, Udit Batra, participate in a fireside chat at the Jefferies Global Healthcare Conference on November 18, 2025 [1] - A live webcast of the event will be available on Waters' Investor Relations website, with a replay accessible for 90 days [2] Company Overview - Waters Corporation is a global leader in analytical instruments, separations technologies, and software, serving various sectors including life sciences, materials, food, and environmental sciences for over 65 years [3] - The company focuses on ensuring the efficacy of medicines, safety of food, purity of water, and quality of everyday products, employing over 7,600 individuals across more than 100 countries [3]

Core Insights - Waters Corporation has launched the Charged Aerosol Detector (CAD) designed for seamless integration with Waters Empower Software, which is widely used for regulatory submissions in the pharmaceutical industry [1][5][10] - The CAD enables near-universal detection of a wide range of analytes, including those difficult to measure with traditional methods, enhancing the capabilities of laboratories in various sectors [2][3][7] Product Features - The CAD provides sensitive and reproducible measurements of analytes with little or no UV absorption, making it suitable for characterizing small molecules, biopharmaceuticals, food additives, and environmental pollutants [3][4] - It addresses common issues faced by users of multi-vendor LC-CAD configurations, such as dropped communications, with 70% of users reporting these problems [4][7][10] - The detector is compatible with various Waters liquid chromatography systems, including the Alliance iS HPLC System and ACQUITY UPLC Systems, ensuring broad applicability [4][5] Market Position - Waters Empower Software is utilized for approximately 80% of novel drug submissions to regulatory authorities, highlighting its critical role in the pharmaceutical industry [1][10] - The introduction of the CAD reinforces Waters' commitment to providing a comprehensive range of liquid chromatography detectors that are compatible with Empower Software, enhancing the user experience and operational efficiency [5][9] Availability - The Waters Charged Aerosol Detector is currently available for pre-order, with shipments expected to begin in April 2026 [5]

Core Viewpoint - The 10th China Analytical Instrument Academic Conference focuses on the theme "AI Empowerment and Innovative Transformation," exploring the impact of AI on the performance enhancement, functional expansion, and application development of analytical instruments [2][5]. Group 1: Conference Overview - The conference was held on November 7, 2025, at the Srit International Hotel in Xi'an, Shaanxi Province, organized by the Analytical Instrument Branch of the China Instrument and Control Society and hosted by Xi'an Jiaotong University [3][5]. - Over 500 industry leaders, innovative enterprise representatives, and young researchers attended the conference, with more than 100 experts sharing reports on AI's influence on analytical instruments [5][11]. Group 2: Keynote Addresses - The conference featured significant addresses from various experts, including the Director of the Analytical Instrument Branch, who highlighted the importance of high-end instruments in China's technological self-reliance and innovation [10]. - Professor He Langchong from Xi'an Jiaotong University emphasized the establishment of a large-scale shared experimental center valued at 265 million yuan, which provides access to advanced equipment for over 20,000 users annually [11]. Group 3: Awards and Recognition - The "Zhu Liangyi Analytical Instrument Innovation Award" was established to honor contributions to the analytical instrument field, with three sub-awards: Innovation Achievement Award, Youth Innovation Award, and Application Innovation Award [24][25]. - The 2025 award winners included institutions and individuals recognized for their innovative projects, such as the high-time-resolution weak current measurement instrument and single-cell metabolite analysis mass spectrometer [28][36]. Group 4: Future Directions - The conference included discussions on the integration of AI in analytical chemistry, with experts presenting on topics such as the principles of large models and their application in economic development [17][41]. - The event also featured a special exhibition showcasing over 30 domestic and international companies presenting new technologies and products, facilitating extensive exchanges among participants [44].